<?xml version="1.0" encoding="UTF-8"?>
<svg height="778.0" width="557.948" xmlns="http://www.w3.org/2000/svg">
 <g id="page" xmlns:svgx="http://www.xml-cml.org/schema/svgx">
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:1.0;" d="M62.360 53.720 L545.670 53.720 "/>
  <g begin="text">
   <text y="49.34" x="62.362,66.842,71.322,74.862,77.672,82.052,85.182,87.962,92.542,96.922,100.462,104.002,105.882,110.362,115.052,117.832,123.042,125.022,127.802,133.012,138.222,141.002,143.922,148.502,153.712,156.632" svgx:width="0.45,0.45,0.35,0.28,0.44,0.31,0.28,0.46,0.44,0.35,0.35,0.19,0.45,0.47,0.28,0.52,0.2,0.28,0.52,0.52,0.28,0.29,0.46,0.52,0.29,0.28" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Poster session 2, 20 (s1) </text>
   <text y="49.34" x="530.672,535.672,540.672" svgx:width="0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">453</text>
  </g>
  <g begin="text">
   <text y="768.0" x="355.802,363.932,368.622,370.502,373.312,375.192,380.092,381.972,386.352,389.132,393.712,397.562,399.442,403.822,406.952,411.432,414.972,416.852,420.392,423.172,425.572,430.052,434.742,437.872,442.562,447.252" svgx:width="0.81,0.47,0.19,0.28,0.19,0.49,0.19,0.44,0.28,0.46,0.38,0.19,0.44,0.31,0.45,0.35,0.19,0.35,0.28,0.24,0.45,0.47,0.31,0.47,0.47,0.19" style="fill:rgb(0,0,0);font-family:GillSansStd-Italic;font-size:10.0px;stroke:none;">Multiple Sclerosis Journal</text>
   <text y="768.0" x="449.132,451.912,456.912,461.912,466.912,471.912,474.102,476.882,481.882,486.882,489.072,491.852,495.082,499.662,504.662,507.892,510.672,515.672,520.672,525.672,530.672,535.672,540.672" svgx:width="0.28,0.5,0.5,0.5,0.5,0.22,0.28,0.5,0.5,0.22,0.28,0.32,0.46,0.5,0.32,0.28,0.5,0.5,0.5,0.5,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;"> 2014; 20: (S1) 285–496</text>
  </g>
  <g begin="text">
   <text y="768.0" x="61.186,68.896,72.746,74.936,77.126,80.976,85.246,89.516,94.306,99.306,104.306,109.206,111.396,115.776,121.296" svgx:width="0.77,0.38,0.22,0.22,0.38,0.43,0.43,0.48,0.5,0.5,0.5,0.22,0.44,0.55,0.77" style="fill:rgb(0,0,0);font-family:GillSansStd;font-size:10.0px;stroke:none;">msj.sagepub.com</text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.25;" d="M62.360 435.160 L98.110 435.160 "/>
  <g begin="text">
   <text y="76.959" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="76.959" x="114.859,120.358,124.858,128.854,131.005,135.505,138.502,142.498,145.999,149.995,154.495,158.491,162.487,164.638,169.138,172.135,174.286,178.282,182.782,185.284,187.786,190.783,194.284,200.287,202.438,206.938,209.44,212.437,216.937,220.438,222.589,225.586,229.087,235.09,241.588,244.585,246.736,250.732,255.232,257.734,260.236,264.736,269.236,273.736,276.238,280.234,283.735,285.886,288.388,291.889,294.04,298.036" svgx:width="0.61,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.33,0.39,0.67,0.72,0.33,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.28,0.39,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The presence of anti-JC virus (JCV) antibodies is a </text>
   <text y="87.957" x="62.362,65.359,67.861,71.362,75.862,77.725,80.722,84.718,88.714,91.216,95.716,98.713,100.576,103.573,108.073,111.07,112.933,117.433,120.43,124.93,129.43,132.427,136.423,139.924,143.425,145.927,150.427,154.423,156.286,163.288,167.788,170.29,172.792,175.294,178.291,182.791,186.787,190.783,193.285,195.148,197.65,201.646,206.146,210.646,215.146,219.142,223.642,227.638,231.634,236.134,240.634,244.63,247.132,251.632,256.132,260.128,262.63,267.13,271.63,273.493,276.49,281.494,289.495,294.994,297.991" svgx:width="0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.33,0.5,0.33,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.33,0.56,0.89,0.61,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">risk factor for progressive multifocal leukoencephalopathy (PML) </text>
   <text y="98.955" x="62.362,66.862,70.858,75.358,79.354,81.856,86.356,90.856,97.858,101.854,106.354,108.856,111.106,114.094,116.596,121.096,123.346,126.334,130.834,134.83,137.332,141.328,143.83,146.332,150.328,154.828,161.83,165.826,170.326,172.576,175.564,178.561,185.059,190.558,196.057,199.054,202.051,204.553,207.55,211.546,215.542,218.044,222.04,226.54,228.79,231.778,238.78,243.28,245.782,248.284,250.786,255.286,257.788,261.784,264.034,267.022,270.523,274.519,277.021,281.017,284.014,288.514,292.015,294.517,298.018" svgx:width="0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.5,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.72,0.61,0.61,0.33,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.55,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">development in natalizumab (NTZ)-treated multiple sclerosis </text>
   <text y="109.953" x="62.362,65.359,73.36,78.364,81.361,83.611,86.59,91.09,95.086,97.588,100.09,104.086,108.586,111.088,114.589,116.839,119.089,121.573,128.071,132.067,136.063,140.563,143.56,148.06,150.562,155.062,159.562,161.812,164.791,167.293,171.793,174.043,177.022,180.019,184.015,188.011,192.007,196.507,199.009,201.259,204.238,207.739,210.241,214.741,219.241,221.743,225.739,229.24,231.49,234.469,237.97,243.973,250.309,252.559,255.538,258.535,262.531,266.527,270.523,273.025,275.527,280.027,284.023,286.525,289.027,293.527,298.027" svgx:width="0.33,0.89,0.56,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.72,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.44,0.44,0.44,0.5,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(MS) patients. According to recent studies JCV reactivation </text>
   <text y="120.951" x="62.362,66.862,70.858,74.854,79.354,82.351,85.852,88.552,93.052,97.552,100.549,103.051,107.551,112.051,114.751,121.249,126.748,132.247,134.947,137.449,141.949,145.945,148.942,152.938,157.438,161.938,164.638,168.634,173.134,177.634,180.334,182.836,186.832,190.828,195.328,198.829,201.529,204.031,208.531,211.231,215.227,219.727,222.427,224.929,229.429,233.425,236.422,240.418,244.414,247.915,251.911,254.611,257.113,261.613,264.313,266.815,271.315,275.311,278.011,280.513,285.013,289.513,293.509,298.009" svgx:width="0.5,0.44,0.44,0.5,0.33,0.39,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.72,0.61,0.61,0.25,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">occurs during NTZ therapy and leads to an increase in the index </text>
   <text y="131.949" x="62.362,64.864,68.86,73.36,77.356,79.858,83.359,85.384,89.884,92.881,94.906,98.902,103.402,105.904,108.406,111.403,114.904,120.907,127.243,129.268,133.264,137.764,140.266,142.768,147.268,151.768,156.268,158.77,162.766,166.267,168.517,170.542,175.546,180.046,183.043,185.545,190.045,194.041,197.038,204.04,208.54,211.537,215.533,217.783,219.808,223.804,228.304,230.329,234.325,238.825,241.327,243.829,246.826,250.327,256.33,262.0,264.997,271.495,275.995,278.02,280.522,285.022,289.522,293.518,298.018" svgx:width="0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.78,0.5,0.33,0.44,0.25,0.25,0.44,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.33,0.72,0.5,0.25,0.28,0.5,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">levels of anti-JCV antibodies. Furthermore, an anti-JCV-Ab index </text>
   <text y="142.947" x="62.362,64.864,68.86,73.36,77.356,79.858,82.108,83.593,88.093,91.09,93.34,94.825,98.821,103.321,107.821,112.321,116.317,118.567,120.052,125.128,129.628,131.878,136.378,138.628,140.113,143.11,147.61,152.11,154.36,155.845,160.345,163.342,165.844,170.344,173.341,175.591,177.076,179.578,186.58,193.582,198.082,202.582,207.082,210.583,215.083,219.583,224.083,227.08,231.076,234.577,238.078,240.58,245.08,249.076,251.326,252.811,255.313,258.31,262.306,266.302,268.804,275.806,279.802,284.302,286.804,289.054,290.539,295.039,298.036" svgx:width="0.28,0.44,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.25,0.55,0.56,0.5,0.25,0.5,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.5,0.33,0.28,0.5,0.33,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">level of above &gt;1.5 (no prior immunosuppressive treatment of </text>
   <text y="153.945" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.611,94.888,99.388,102.385,106.381,110.377,114.877,119.377,123.877,127.378,131.374,135.874,138.871,141.121,143.398,147.898,151.894,155.395,157.645,159.922,164.422,168.418,172.414,176.914,179.164,181.441,184.942,189.442,193.942,198.442,202.438,205.939,208.441,212.437,216.937,219.187,221.464,223.966,228.466,230.716,232.993,236.989,241.489,244.486,247.483,251.479,253.981,257.977,260.479,264.475,266.725,269.002,275.5,278.002,280.504,285.004,287.254,289.531,293.527,298.027" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.33,0.44,0.44,0.5,0.5,0.5,0.39,0.44,0.5,0.33,0.25,0.55,0.5,0.44,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.44,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients preexposed) has been suggested to correlate with an </text>
   <text y="164.943" x="62.362,64.864,69.364,73.36,76.357,80.353,84.349,87.85,91.846,96.346,98.596,103.6,111.601,116.767,119.017,122.014,124.516,128.017,132.517" svgx:width="0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">increased PML risk.</text>
   <text y="175.941" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="175.941" x="108.037,112.906,117.406,119.593,123.589,128.089,132.589,135.091,139.591,142.588,146.584,148.771,152.767,157.267,159.454,163.45,166.951,170.452,174.952,178.948,181.45,185.446,187.948,190.45,194.95,199.45,201.637,206.137,210.133,212.635,219.133,223.129,227.125,231.625,233.812,236.314,240.814,244.81,246.997,250.993,255.493,257.995,260.497,263.494,266.995,272.998,279.334,281.521,285.517,290.017,292.519,295.021" svgx:width="0.61,0.5,0.25,0.44,0.5,0.5,0.28,0.5,0.33,0.44,0.25,0.44,0.5,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">To explore an association between the anti-JCV anti-</text>
   <text y="186.939" x="62.362,66.862,71.362,75.862,80.362,82.612,83.701,86.203,90.703,95.203,99.199,103.699,105.949,107.038,109.54,114.04,116.29,117.379,123.877,129.376,134.875,137.872,140.374,143.371,147.367,151.363,153.865,157.861,162.361,164.611,165.7,173.701,178.705,180.955,182.044,186.544,190.54,193.042,195.544,199.54,204.04,206.542,210.043,212.293,213.382,217.378,221.878,226.378,228.628,229.717,233.713,238.213,242.713,246.709,250.21,252.712,257.212,261.712,263.962,265.042,272.044,276.544,279.046,283.042,287.038,291.538,294.04,298.036" svgx:width="0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.61,0.61,0.33,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.44,0.39,0.28,0.5,0.5,0.25,0.55,0.78,0.5,0.28,0.44,0.44,0.5,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">body index in NTZ-treated MS patients and adhesion molecule </text>
   <text y="197.937" x="62.362,65.359,71.857,79.858,82.855,85.105,89.101,93.601,98.101,101.098,105.094,108.595,112.096,114.598,119.098,123.598,125.848,128.35,132.346,136.846,140.842,143.344,146.845,149.095,153.595,158.095,160.345,162.847,167.347,174.349,178.849,183.349,187.849,191.845,196.345,198.847,202.843,206.344" svgx:width="0.33,0.72,0.89,0.33,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(AM) expression levels on lymphocytes.</text>
   <text y="208.935" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="208.935" x="101.692,109.468,113.464,116.299,118.801,123.301,127.297,129.799,134.299,138.799,142.795,147.295,150.13,154.63,159.13,161.965,169.966,174.97,177.805,182.305,186.301,188.803,191.305,195.301,199.801,202.303,205.804,208.639,215.137,217.639,220.141,224.641,227.476,231.472,234.307,238.807,243.307,246.808,249.31,251.812,254.314,258.814,262.81,265.645,269.641,274.141,276.643,279.145,282.142,285.643,291.646,297.982" svgx:width="0.94,0.44,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We included 16 MS patients with a positive anti-JCV </text>
   <text y="219.933" x="62.362,66.358,70.858,73.36,75.862,80.362,84.862,89.362,93.862,96.112,96.913,99.91,103.411,109.414,115.084,118.081,122.077,126.577,129.574,131.824,132.625,136.126,140.122,143.119,147.619,151.12,153.622,157.618,160.12,164.62,168.121,170.371,171.163,174.16,178.66,183.16,185.41,186.202,194.203,199.207,201.457,202.258,206.758,210.754,213.256,215.758,219.754,224.254,226.756,230.257,232.507,233.299,239.797,242.299,244.801,249.301,251.551,252.352,256.348,260.848,263.35,265.852,268.849,272.35,278.353,284.023,287.02,293.518,298.018" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.33,0.39,0.67,0.72,0.33,0.44,0.5,0.33,0.25,0.55,0.39,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.33,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antibody (JCV-ab) serostatus (12 MS patients with anti-JCV-Ab </text>
   <text y="230.931" x="62.362,64.864,69.364,73.864,77.86,82.36,84.61,87.103,89.605,93.601,98.101,102.097,104.599,106.849,109.342,113.842,116.839,119.089,121.582,125.578,130.078,134.578,139.078,143.074,145.324,147.817,152.893,157.393,159.643,164.143,167.14,169.39,171.883,175.879,180.379,184.879,187.129,189.622,194.122,198.622,200.872,203.365,206.866,212.869,218.539,221.536,225.532,230.032,232.282,234.775,238.276,242.272,245.269,249.769,254.269,258.265,262.765,266.761,269.263,271.765,276.265,280.261,282.511,285.004,293.005,298.009" svgx:width="0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.25,0.55,0.56,0.5,0.25,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.39,0.67,0.72,0.33,0.44,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">index level of above &gt;1.5) and 23 JCV-ab seronegative MS </text>
   <text y="241.929" x="62.362,66.862,70.858,73.36,75.862,79.858,84.358,86.86,90.361,92.611,94.654,99.154,103.654,106.651,109.153,113.653,118.153,120.403,122.446,128.944,134.443,139.942,142.192,144.235,146.737,149.734,153.73,157.726,160.228,167.23,171.226,175.726,178.228,180.478,182.728,184.276,190.774,195.274,197.776,200.278,203.275,206.776,212.779,219.115,221.365,223.408,227.404,231.904,234.406,236.908,241.408,245.908,250.408,254.908,257.158,259.201,262.702,265.204,269.2,271.702,276.202,279.703,281.953,283.996,290.494,294.49,297.991" svgx:width="0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.55,0.72,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">patients during NTZ treatment. Anti-JCV antibody status was </text>
   <text y="252.927" x="62.362,66.862,70.858,73.36,77.356,80.353,87.355,89.857,94.357,98.353,102.853,104.968,111.466,113.968,116.47,120.97,123.085,125.587,130.087,134.083,136.198,141.202,146.701,152.704,158.203,163.702,166.699,171.703,177.868,179.983,183.484,189.487,195.985,201.484,209.485,211.6,217.099,222.598,225.595,230.599,236.602,238.717,241.219,245.215,248.716,251.218,253.468,255.421,260.92,265.42,269.416,271.531,275.527,280.027,284.527,287.524,291.52,295.021" svgx:width="0.5,0.44,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.56,0.61,0.67,0.72,0.61,0.33,0.56,0.72,0.25,0.39,0.67,0.72,0.61,0.89,0.25,0.61,0.61,0.33,0.56,0.72,0.25,0.28,0.44,0.39,0.28,0.25,0.25,0.61,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">determined with the STRATIFY JCVTM ELISA test. The expres-</text>
   <text y="263.925" x="62.362,65.863,68.365,72.865,77.365,79.696,82.198,86.194,90.694,94.69,97.192,100.693,103.015,107.515,110.512,112.843,115.84,121.843,128.341,136.342,139.339,143.839,146.089,148.42,151.417,155.917,158.167,160.498,163.495,167.995,170.245,172.576,178.579,185.077,189.244,193.744,197.74,199.99,202.321,208.324,214.822,219.322,223.822,228.322,230.572,232.894,238.897,245.395,249.895,254.395,256.726,263.224,267.22,270.217,274.213,276.535,283.537,287.533,291.529,295.03" svgx:width="0.39,0.28,0.5,0.5,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.33,0.67,0.72,0.89,0.33,0.5,0.25,0.25,0.33,0.5,0.25,0.25,0.33,0.5,0.25,0.25,0.67,0.72,0.5,0.5,0.44,0.25,0.25,0.67,0.72,0.5,0.5,0.5,0.25,0.25,0.67,0.72,0.5,0.5,0.25,0.72,0.44,0.33,0.44,0.25,0.78,0.44,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sion levels of ICAM-1, -2, -3, CD11a, CD49d, CD29 were meas-</text>
   <text y="274.923" x="62.362,66.862,69.859,73.855,78.355,80.605,85.105,89.605,91.855,97.858,104.356,108.856,113.932,116.02,120.853,123.103,125.353,131.356,137.854,142.354,146.854,151.93,154.18,160.183,162.433,164.683,169.183,173.179,175.681,180.181,183.178,187.174,189.676,191.926,196.426,198.928,201.43,203.932,207.928,210.925,213.175,216.172,222.67,229.168,232.165,234.415,238.411,242.911,247.411,249.661,256.159,262.657,267.994,270.244,274.24,278.236,280.738,283.24,286.741,288.991,293.491,297.991" svgx:width="0.5,0.33,0.44,0.5,0.25,0.5,0.5,0.25,0.67,0.72,0.5,0.56,0.25,0.61,0.25,0.25,0.67,0.72,0.5,0.5,0.56,0.25,0.67,0.25,0.25,0.5,0.44,0.28,0.5,0.33,0.44,0.28,0.25,0.5,0.28,0.28,0.28,0.44,0.33,0.25,0.33,0.72,0.72,0.33,0.25,0.44,0.5,0.5,0.25,0.72,0.72,0.61,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ured on CD3+ T, CD19+ B, natural killer (NK) and NKT cells by </text>
   <text y="285.921" x="62.362,65.359,67.861,72.361,78.859,81.109,85.105,89.605,92.107,96.607,103.609,107.605,110.107,113.104,117.019" svgx:width="0.33,0.28,0.5,0.72,0.25,0.44,0.5,0.28,0.5,0.78,0.44,0.28,0.33,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">flow cytometry.</text>
   <text y="296.919" x="62.362,68.86,72.856,76.357,81.361,83.863,86.86,90.361,93.358" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="296.919" x="95.68,103.456,107.452,109.774,112.771,117.271,121.771,126.271,130.771,133.093,137.089,139.411,142.912,145.414,149.914,154.414,156.916,159.913,162.415,166.411,170.407,174.907,177.409,179.731,184.231,186.733,191.233,195.733,199.729,202.726,205.048,208.045,212.545,217.621,222.121,224.371,228.871,233.371,237.871,240.868,243.19,246.691,251.191,254.188,257.185,261.181,265.177,269.173,271.495,275.491,279.991,284.491,287.488,291.484,294.985" svgx:width="0.94,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.44,0.25,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25,0.39,0.5,0.33,0.33,0.44,0.44,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">We found a significant higher (p=0.015) surface expres-</text>
   <text y="307.917" x="62.362,65.863,68.365,72.865,77.365,79.381,83.881,86.878,88.894,94.897,101.395,105.562,110.062,114.058,116.074,120.574,125.074,127.09,133.093,136.09,140.086,144.082,146.584,149.086,152.587,154.603,157.105,161.605,163.621,171.622,176.626,178.642,183.142,187.138,189.64,192.142,196.138,200.638,203.14,206.641,208.657,215.155,217.657,220.159,224.659,226.675,230.671,235.171,237.673,240.175,243.172,246.673,252.676,259.012,261.028,265.024,269.524,272.026,274.528,279.028,283.528,288.028,290.53,294.526,298.027" svgx:width="0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.67,0.72,0.5,0.5,0.44,0.25,0.5,0.5,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.28,0.5,0.25,0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">sion of CD11a on B-cells in MS patients with anti-JCV antibodies </text>
   <text y="318.915" x="62.362,64.864,69.364,73.864,77.86,82.36,84.61,87.922,92.998,97.498,99.748,104.248,106.498,109.81,113.806,118.306,125.308,129.808,133.804,136.801,140.797,145.297,147.547,150.859,153.361,157.861,160.111,163.423,166.924,172.927,178.597,181.594,188.092,192.592,194.842,198.154,201.655,205.651,208.648,213.148,217.648,221.644,226.144,230.14,232.642,235.144,239.644,243.64,245.89,249.202,257.203,262.207,264.457,267.769,272.269,276.265,278.767,281.269,285.265,289.765,292.267,295.768,298.018" svgx:width="0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.56,0.5,0.25,0.5,0.25,0.55,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.67,0.72,0.33,0.72,0.5,0.25,0.55,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">index &gt;1.5 compared to JCV-Ab seronegative MS patients. </text>
   <text y="329.913" x="62.362,67.366,71.866,74.863,77.365,81.865,85.861,88.858,95.86,100.36,103.357,107.353,109.603,110.908,113.41,117.91,121.906,124.903,128.899,131.149,132.454,138.952,142.948,146.449,148.699,150.004,154.0,156.25,157.555,162.055,166.555,170.056,172.558,175.06,177.562,182.062,186.058,188.308,189.613,193.609,198.109,201.106,204.103,208.099,210.601,214.597,217.099,219.601,224.101,228.601,230.851,232.156,236.656,240.652,243.154,249.652,253.648,257.644,262.144,264.394,265.699,269.695,274.195,276.697,279.199,282.196,285.697,291.7,298.036" svgx:width="0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.78,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Furthermore there was a positive correlation between anti-JCV </text>
   <text y="340.911" x="62.362,66.358,70.858,73.36,75.862,80.362,84.862,89.362,93.862,96.112,98.695,101.197,105.697,110.197,114.193,118.693,120.943,123.526,127.522,132.022,136.522,138.772,141.355,145.351,149.851,154.351,157.348,161.344,164.845,168.346,170.848,175.348,179.848,182.098,184.681,187.183,191.179,195.679,199.675,202.177,205.678,207.928,210.511,215.011,218.008,220.258,222.841,225.838,231.841,238.339,246.34,249.337,253.837,256.087,258.67,263.17,267.67,269.92,272.503,278.506,281.503,285.499,289.495,291.997,294.499,298.0" svgx:width="0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.33,0.67,0.72,0.89,0.33,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">antibody index and expression levels of ICAM-1 on B-cells </text>
   <text y="351.909" x="62.362,65.359,69.859,74.935,79.435,81.685,86.185,90.685,95.185,97.435,99.685,102.682,107.758,112.258,114.508,119.008,123.508,128.008,131.005" svgx:width="0.33,0.5,0.56,0.5,0.25,0.5,0.5,0.5,0.25,0.25,0.33,0.56,0.5,0.25,0.5,0.5,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(p=0.007, r=0,654).</text>
   <text y="362.907" x="62.362,68.86,73.36,78.364,82.36,84.862,89.866,93.367,95.869,100.369,105.373,108.874,111.871" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="362.907" x="116.641,123.139,127.639,130.636,132.886,135.406,139.906,143.902,146.404,150.4,152.65,155.17,157.672,162.172,166.672,169.174,173.17,177.166,179.668,183.664,185.914,188.434,192.43,194.68,197.2,201.7,206.2,208.702,212.698,217.198,219.7,222.202,226.198,228.7,230.95,233.47,235.972,238.474,242.974,247.474,249.724,252.244,256.744,260.74,263.242,269.74,273.736,277.732,282.232,284.482,287.002,289.504,294.004,298.0" svgx:width="0.72,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Our data indicate a potential link between the </text>
   <text y="373.905" x="62.362,65.359,69.355,73.351,77.347,81.847,84.349,88.849,91.846,94.348,96.85,99.352,103.852,107.848,112.348,116.848,118.783,123.283,127.279,129.781,132.778,134.713,140.212,144.55,151.048,154.045,158.545,160.48,163.477,169.48,175.978,180.145,184.645,188.641,191.638,194.14,197.137,203.14,209.638,217.639,220.636,225.136,227.071,231.571,236.071,238.006,244.009,247.006,251.002,254.998,257.5,260.002,263.503,265.438,269.434,273.934,278.434,280.369,283.87,289.873,291.646,297.982" svgx:width="0.33,0.44,0.44,0.44,0.5,0.28,0.5,0.33,0.28,0.28,0.28,0.5,0.44,0.5,0.5,0.25,0.5,0.44,0.28,0.33,0.25,0.61,0.56,0.72,0.33,0.5,0.25,0.33,0.67,0.72,0.5,0.5,0.44,0.33,0.28,0.33,0.67,0.72,0.89,0.33,0.5,0.25,0.5,0.5,0.25,0.67,0.33,0.44,0.44,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.25,0.39,0.67,0.25,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">receptor/ligand pair LFA-1 (CD11a)/ICAM-1 on B-cells and JC V </text>
   <text y="384.903" x="62.362,65.863,69.859,72.856,77.356,80.857,83.359,87.355,89.857,94.357,97.858" svgx:width="0.39,0.44,0.33,0.5,0.39,0.28,0.44,0.28,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">serostatus.</text>
   <text y="411.903" x="62.362,67.861,72.361,76.861" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P882</text>
   <text y="422.901" x="62.362,68.86,73.864,76.861,79.363,81.613,86.113,92.611,94.861,99.361,101.863,105.859,110.863,114.364,116.614,121.114,126.118,129.115,131.617,136.621,141.121,146.125,148.627,152.623,156.124,158.374,160.876,165.88,168.13,173.134,177.13,182.134,184.636,189.136,192.133,196.129,198.631,202.627,204.877,212.374,217.378,219.88,222.877,225.379,230.383,232.885,236.881,239.131,242.632,246.628,249.13,253.126,257.122,261.622,265.123,267.625" svgx:width="0.72,0.56,0.33,0.28,0.25,0.5,0.72,0.25,0.5,0.28,0.44,0.56,0.39,0.25,0.5,0.56,0.33,0.28,0.56,0.5,0.56,0.28,0.44,0.39,0.25,0.28,0.56,0.25,0.56,0.44,0.56,0.28,0.5,0.33,0.44,0.28,0.44,0.25,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Anti JC virus antibodies in pediatric multiple sclerosis</text>
   <text y="433.899" x="62.362,67.366,69.616,76.114,80.614,85.114,89.614,94.114" svgx:width="0.56,0.25,0.72,0.5,0.5,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">P Huppke</text>
   <text y="431.439" x="98.11" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="433.959" x="101.035,103.285,105.535,112.033,114.283,120.781,125.281,132.283,139.285,143.281" svgx:width="0.25,0.25,0.72,0.25,0.72,0.5,0.78,0.78,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, H Hummel</text>
   <text y="431.439" x="145.783" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="433.959" x="148.708,150.958,153.208,159.706,161.956,167.454,169.956,172.458,176.454,180.954,185.454,189.451,192.447,196.947,200.943" svgx:width="0.25,0.25,0.72,0.25,0.61,0.28,0.28,0.44,0.5,0.5,0.44,0.33,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, D Ellenberger</text>
   <text y="431.439" x="203.94" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="433.959" x="206.865,209.115,211.365,216.369,218.619,223.623,226.62,230.616,233.118,236.115,240.111,244.611,249.111,252.108,254.61,259.11" svgx:width="0.25,0.25,0.56,0.25,0.56,0.33,0.44,0.28,0.33,0.44,0.5,0.5,0.33,0.28,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, S Pfeifenbring</text>
   <text y="431.439" x="263.609" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="433.959" x="266.534,268.784,271.034,279.53" svgx:width="0.25,0.25,0.94,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, W </text>
   <text y="444.957" x="62.36,67.364,69.866,73.862,76.859" svgx:width="0.56,0.28,0.44,0.33,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Stark</text>
   <text y="442.439" x="81.361" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="444.959" x="84.286,86.536,88.786,94.789,97.039,103.537,108.037,112.537,117.037,121.537" svgx:width="0.25,0.25,0.67,0.25,0.72,0.5,0.5,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Huppke</text>
   <text y="442.439" x="125.533" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="444.959" x="128.458,130.708,132.958,141.454,143.704,149.707,152.704,157.204,161.2" svgx:width="0.25,0.25,0.94,0.25,0.67,0.33,0.5,0.44,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, W Brück</text>
   <text y="442.439" x="165.699" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">3</text>
   <text y="444.959" x="168.624,170.874,173.124,176.625,178.875,185.373,189.369,192.366,194.868,199.368,203.364" svgx:width="0.25,0.25,0.39,0.25,0.72,0.44,0.33,0.28,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, J Gärtner</text>
   <text y="442.439" x="206.361" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="453.437" x="62.363" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="455.959" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,112.528,116.524,121.024,123.526,127.522,132.022,134.524,136.774,142.777,146.773,151.273,153.775,157.771,161.272,163.522,165.772,172.27,176.266,180.766,184.267,188.767,191.017,196.516,201.016,205.516,210.016,213.517,216.019,218.269,224.767,229.267,231.769,235.765,239.761,243.262,246.763,249.265,251.767,255.763,258.013,260.263,265.762,269.758,274.258,276.76,281.26,283.762,287.263,289.765,293.761" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.5,0.39,0.5,0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.61,0.44,0.5,0.28,0.5,0.28,0.39,0.28,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Medical Center, Georg August University, Pediatric </text>
   <text y="466.957" x="62.362,68.365,72.361,76.861,80.362,84.862,87.364,91.864,96.364,100.36,102.61,104.86,111.358,115.858,118.36,120.862,123.364,127.864,132.364,136.36,140.86,143.11,145.36,151.858,155.854,159.355,165.853,170.353,174.853,178.849,181.099" svgx:width="0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neurology, Göttingen, Germany, </text>
   <text y="464.439" x="183.348" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="466.959" x="186.273,192.771,197.271,199.773,203.769,207.765,211.266,214.767,217.269,219.771,223.767,226.017,233.514,237.51,242.01,244.512,248.508,253.008,255.51,257.76,263.763,267.759,272.259,274.761,278.757,282.258,284.508" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Medical Center, </text>
   <text y="477.957" x="62.361,68.859,72.855,77.355,80.856,85.356,87.606,93.105,97.605,102.105,106.605,110.106,112.608,114.858,121.356,125.856,128.358,132.354,136.35,139.851,143.352,145.854,148.356,152.352,154.602,156.852,161.352,163.854,168.354,170.856,173.358,176.859,179.361,181.863,185.859,189.36,191.61,193.86,200.358,204.858,207.36,209.862,212.364,216.864,221.364,225.36,229.86,232.11,234.36,240.858,244.854,248.355,254.853,259.353,263.853,267.849,270.099" svgx:width="0.72,0.44,0.5,0.39,0.5,0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25,0.5,0.28,0.5,0.28,0.28,0.39,0.28,0.28,0.44,0.39,0.25,0.25,0.72,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Georg August University, Statistics, Göttingen, Germany, </text>
   <text y="486.439" x="62.362" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">3</text>
   <text y="488.959" x="65.287,71.785,76.285,78.787,82.783,86.779,90.28,93.781,96.283,98.785,102.781,105.031,112.528,116.524,121.024,123.526,127.522,132.022,134.524,136.774,142.777,146.773,151.273,153.775,157.771,161.272,163.522,165.772,172.27,176.266,180.766,184.267,188.767,191.017,196.516,201.016,205.516,210.016,213.517,216.019,218.269,224.767,229.267,231.769,235.765,239.761,243.262,246.763,249.265,251.767,255.763,258.013" svgx:width="0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.83,0.44,0.5,0.28,0.44,0.5,0.28,0.25,0.67,0.44,0.5,0.28,0.44,0.39,0.25,0.25,0.72,0.44,0.5,0.39,0.5,0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.72,0.5,0.28,0.44,0.44,0.39,0.39,0.28,0.28,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">University Medical Center, Georg August University, </text>
   <text y="499.957" x="62.362,68.365,72.361,76.861,80.362,84.862,89.362,93.862,96.364,100.864,105.364,107.866,112.366,116.866,120.862,123.112,125.362,131.86,136.36,138.862,141.364,143.866,148.366,152.866,156.862,161.362,163.612,165.862,172.36,176.356,179.857,186.355,190.855,195.355" svgx:width="0.67,0.44,0.5,0.39,0.5,0.5,0.5,0.28,0.5,0.5,0.28,0.5,0.5,0.44,0.25,0.25,0.72,0.5,0.28,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.72,0.44,0.39,0.72,0.5,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Neuropathology, Göttingen, Germany</text>
   <text y="526.957" x="62.362,68.365,72.865,76.861,81.865,86.365,90.199,94.699,99.703,104.707,109.711,112.708" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="526.957" x="114.931,121.429,125.425,127.927,131.923,134.425,136.927,140.923,145.423,152.425,156.421,160.921,163.144,167.644,171.64,175.141,177.364,181.864,185.86,189.856,194.356,196.579,200.08,204.58,209.08,215.578,220.078,222.301,224.803,229.303,231.526,236.026,240.022,242.245,246.241,248.464,252.964,256.96,259.957,264.457,266.68,270.676,273.511,276.508,280.504,284.5,287.002,289.504,294.004,298.0" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.5,0.44,0.39,0.25,0.5,0.44,0.44,0.5,0.25,0.39,0.5,0.5,0.72,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.44,0.25,0.5,0.44,0.33,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab has been shown to be a very effective </text>
   <text y="537.955" x="62.362,64.864,67.861,71.857,75.853,78.355,85.357,89.353,93.853,96.355,98.551,101.053,105.553,107.749,111.25,115.246,119.746,123.742,126.739,130.735,132.931,137.431,141.427,145.927,148.429,152.425,154.927,157.924,160.426,164.422,166.618,173.62,178.12,180.622,183.124,185.626,190.126,192.628,196.624,198.82,202.321,206.317,208.819,212.815,215.812,220.312,223.813,226.315,229.816,232.066,234.262,239.266,243.766,245.962,248.959,252.955,255.952,258.148,262.648,267.148,269.344,273.34,277.336,280.837,284.833,288.334,290.53,295.03,298.027" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.28,0.5,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.5,0.44,0.5,0.28,0.44,0.28,0.33,0.28,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.56,0.5,0.25,0.33,0.44,0.33,0.25,0.5,0.5,0.25,0.44,0.44,0.39,0.44,0.39,0.25,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment in severe pediatric multiple sclerosis. So far no cases of </text>
   <text y="548.953" x="62.362,66.862,69.859,74.359,78.859,81.856,85.852,89.353,92.854,95.356,99.856,103.852,106.102,107.191,114.193,118.693,121.195,123.697,126.199,129.196,133.696,137.692,141.688,144.19,146.44,147.529,150.031,154.027,158.527,163.027,167.527,171.523,176.023,180.019,184.015,188.515,193.015,197.011,199.513,204.013,208.513,212.509,215.011,219.511,224.011,226.261,227.35,231.85,235.846,240.346,244.342,246.592,247.681,252.181,256.177,260.173,264.673,266.923,268.012,271.009,275.005,279.505,284.005,287.002,289.504,293.5,298.0" svgx:width="0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.5,0.44,0.44,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">progressive multifocal leukoencephalopathy have been reported </text>
   <text y="559.951" x="62.362,64.864,69.364,71.407,78.409,82.909,85.411,87.913,90.415,94.915,97.417,101.413,103.456,106.957,110.953,113.455,117.451,120.448,124.948,128.449,130.951,134.452,136.495,140.995,144.991,147.493,149.995,153.991,158.491,160.993,164.494,166.537,169.039,173.539,175.582,178.084,182.584,185.086,188.587,190.63,194.626,199.126,203.122,205.165,209.665,212.662,217.162,221.662,226.162,228.412,230.455,235.459,238.456,242.452,246.952,250.948,253.45,257.446,261.946,265.942,269.938,271.981,274.978,279.478,282.475,284.518,288.514,293.014,295.516,298.018" svgx:width="0.28,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.44,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.56,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">in multiple sclerosis patients in this age group. Prevalence for anti </text>
   <text y="570.949" x="62.362,65.863,71.866,74.152,78.652,81.154,84.151,88.651,92.152,94.438,98.434,102.934,105.436,107.938,112.438,116.938,121.438,123.94,127.936,131.437,133.723,136.225,140.725,143.011,147.007,151.507,154.009,156.511,161.011,164.008,168.004,172.504,174.79,179.29,183.286,185.788,190.288,196.786,199.072,203.068,207.568,211.564,213.85,218.35,222.85,225.136,229.636,233.632,237.133,239.419,243.919,247.915,251.911,256.411,258.697,261.694,265.69,270.19,274.69,277.687,280.189,284.185,288.685,290.971,293.473,297.973" svgx:width="0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.5,0.33,0.44,0.5,0.25,0.5,0.44,0.28,0.5,0.72,0.25,0.44,0.5,0.44,0.25,0.5,0.5,0.25,0.5,0.44,0.39,0.25,0.5,0.44,0.44,0.5,0.25,0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">JC virus antibodies in children below age 21 has been reported to </text>
   <text y="581.947" x="62.362,66.862,70.858,73.108,77.608,82.108,89.605,91.855,94.357,98.857,101.107,103.609,108.109,112.105,114.355,120.853,125.353,127.855,130.357,134.353,138.853,141.103,146.107,148.609,152.605,155.107,159.103,162.604" svgx:width="0.5,0.44,0.25,0.5,0.5,0.83,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.72,0.5,0.28,0.28,0.44,0.5,0.25,0.56,0.28,0.44,0.28,0.44,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">be 21% in the United States.</text>
   <text y="592.945" x="62.362,69.364,74.368,77.365,81.361,85.357,88.354,90.856,95.356,99.352,102.853,105.85" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="592.945" x="108.838,115.336,118.837,121.087,121.825,124.327,128.827,132.823,135.073,135.811,142.813,146.809,149.311,153.811,156.808,159.31,161.812,166.312,168.562,169.3,173.8,176.797,179.047,179.785,184.285,188.281,190.783,193.285,197.281,201.781,204.283,207.784,210.034,210.772,215.272,219.268,223.264,227.764,230.266,234.766,239.266,241.516,242.254,246.25,249.751,253.747,257.743,260.245,264.241,266.743,269.245,273.745,278.245,280.495,281.233,283.735,288.235,292.231,295.021" svgx:width="0.72,0.39,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.28,0.5,0.33,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.44,0.39,0.44,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.33,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">As the majority of patients needing escalation ther-</text>
   <text y="603.943" x="62.362,66.358,70.858,75.358,77.608,78.427,80.929,85.429,87.679,88.498,91.0,95.5,99.496,101.746,102.565,109.063,113.059,116.056,123.058,127.054,131.554,133.804,134.623,138.619,142.615,147.115,149.617,153.613,156.61,158.86,159.679,162.676,167.176,170.173,172.423,173.242,181.243,186.247,188.497,189.316,191.818,196.318,198.568,199.387,203.383,207.883,210.385,212.887,217.387,221.887,226.387,230.887,235.387,237.637,238.456,242.452,246.952,251.452,253.702,254.521,258.517,263.017,267.517,270.019,274.015,277.516,281.512,285.508,290.008,294.004,298.0" svgx:width="0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.44,0.33,0.78,0.44,0.5,0.25,0.55,0.44,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.89,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.44,0.39,0.44,0.44,0.5,0.44,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">apy in the German center for MS in childhood and adolescence </text>
   <text y="614.941" x="62.362,68.86,72.856,76.357,78.832,81.829,86.329,90.829,95.329,99.829,102.304,104.806,109.306,111.781,116.281,120.277,122.752,126.253,130.249,133.246,137.746,142.246,146.746,150.247,152.749,155.251,157.753,162.253,166.249,168.724,171.721,176.221,179.218,181.693,185.689,190.189,192.691,195.193,197.668,201.169,207.172,209.647,214.147,216.649,219.646,224.146,227.647,230.122,234.118,238.618,241.12,243.622,248.122,252.622,257.122,259.624,263.62,267.121,269.596,276.094,280.09,282.565,286.561,291.061,295.057" svgx:width="0.72,0.44,0.39,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.25,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.25,0.44,0.5,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was found to be seropositive for anti JC virus antibodies we ana-</text>
   <text y="625.939" x="62.362,64.864,69.364,73.36,77.356,81.856,84.106,84.961,87.463,91.963,95.959,98.209,99.064,103.564,106.561,110.557,115.057,119.053,121.555,125.551,130.051,134.047,138.043,140.293,141.148,145.648,148.645,150.895,151.75,155.746,160.246,162.748,165.25,167.5,168.355,171.856,177.859,180.109,180.964,185.464,187.966,190.963,195.463,198.964,201.214,202.069,206.065,210.565,213.067,215.569,220.069,224.569,229.069,231.571,235.567,239.068,241.318,243.568,244.423,246.925,251.425,255.421,257.671,258.526,262.522,267.022,271.522,276.022,280.018,283.015,286.516,289.018,293.518,298.018" svgx:width="0.28,0.5,0.44,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.25,0.55,0.39,0.67,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lyzed the prevalence of anti JC virus antibodies, the conversion </text>
   <text y="636.937" x="62.362,65.359,69.355,71.857,75.853,78.616,82.612,87.112,91.612,94.375,96.877,101.377,105.373,108.136,110.638,115.138,118.135,120.637,125.137,129.133,133.633,137.629,141.625,144.388,148.888,151.885,154.648,157.15,161.65,165.646,168.409,172.405,176.905,179.407,181.909,184.672,188.173,194.176,196.939,201.439,203.941,206.938,211.438,214.939,217.702,221.698,226.198,228.7,231.202,235.702,240.202,244.702,249.202,251.965,255.466,257.968,261.964,264.466,268.966,272.467,275.23,279.73,284.23,286.993,289.495,293.995,297.991" svgx:width="0.33,0.44,0.28,0.44,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.33,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.25,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.5,0.5,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rate and the influence of the anti JC virus antibody status on the </text>
   <text y="647.935" x="62.362,66.358,68.86,71.362,75.862,78.364,82.36,86.356,88.858,91.108,95.104,99.604,104.104,107.101,110.602,114.598,116.848,119.35,123.85,126.1,130.096,132.346,134.848,138.844,141.679,146.179,150.175,152.425,156.925,160.921,165.421,167.923,171.919,174.421,177.418,179.92,183.916,186.166,193.168,197.668,200.17,202.672,205.174,209.674,212.176,216.172,218.422,221.923,225.919,228.421,232.417,235.414,239.914,243.415,245.917,249.418,251.668,255.664,260.164,264.664,269.164,272.161,274.663" svgx:width="0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.28,0.5,0.25,0.44,0.25,0.28,0.44,0.33,0.5,0.44,0.25,0.5,0.44,0.5,0.28,0.44,0.28,0.33,0.28,0.44,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">clinical course in a large pediatric multiple sclerosis cohort.</text>
   <text y="658.933" x="62.362,70.858,74.854,77.851,82.855,87.355,92.359,95.86,98.857" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="658.933" x="101.314,107.812,112.312,114.814,117.316,120.313,123.814,129.817,132.274,136.774,139.276,142.273,146.773,150.274,152.731,156.727,161.227,163.729,166.231,170.731,175.231,179.731,182.233,186.229,189.73,192.187,198.685,202.681,205.678,209.674,212.131,216.127,220.627,224.623,227.125,231.625,235.621,239.617,244.117,246.574,249.076,253.576,256.033,259.534,263.53,266.527,271.027,278.029,280.486,283.987,287.983,294.985" svgx:width="0.72,0.5,0.28,0.28,0.33,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.44,0.5,0.25,0.28,0.5,0.25,0.39,0.44,0.33,0.5,0.78,0.25,0.39,0.44,0.78,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Anti-JC virus antibodies were analyzed in serum sam-</text>
   <text y="669.931" x="62.362,66.862,69.364,73.36,76.861,78.958,85.456,87.958,90.46,94.96,97.462,101.962,104.059,108.559,110.656,117.658,122.158,126.658,129.16,133.66,137.161,139.258,143.758,146.755,148.852,153.352,155.854,159.355,163.351,167.347,170.848,174.844,176.941,181.441,185.941,189.442,193.438,195.94,198.037,202.033,206.533,211.033,213.13,217.63,222.13,225.127,227.629,232.129,236.629,238.726,241.228,245.728,249.724,251.821,255.817,260.317,264.817,267.814,271.315,275.311,277.408,281.908,284.905,287.002,289.504,294.004,298.0" svgx:width="0.5,0.28,0.44,0.39,0.25,0.72,0.28,0.28,0.5,0.28,0.5,0.25,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ples within 6 months of disease onset and during the course of the </text>
   <text y="680.929" x="62.362,66.862,69.364,72.865,76.861,80.857,84.358,88.354,90.604,95.104,98.605,101.107,105.607,110.107,112.357,114.859,119.359,123.355,125.605,129.106,135.109" svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.67,0.72" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">disease using the JCV</text>
   <text y="683.029" x="141.606,145.181" svgx:width="0.61,0.89" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">TM</text>
   <text y="680.959" x="150.381,152.631,159.129,163.629,168.633,172.629,175.131,179.127,183.123" svgx:width="0.25,0.72,0.5,0.56,0.44,0.28,0.44,0.44,0.28" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> DxSelect</text>
   <text y="678.439" x="185.624,189.199" svgx:width="0.61,0.89" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">TM</text>
   <text y="680.959" x="194.399,196.649,199.151,203.147,206.648,209.15" svgx:width="0.25,0.28,0.44,0.39,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;"> test.</text>
   <text y="691.957" x="62.36,68.858,72.854,76.355,81.359,83.861,86.858,90.359,93.356" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="691.957" x="95.444,99.944,104.444,106.694,111.194,118.691,120.779,125.279,128.276,130.364,134.864,139.364,143.864,145.952,150.452,154.448,156.95,159.452,163.448,167.948,170.45,173.951,176.039,182.537,186.533,189.53,193.526,195.614,198.611,203.111,207.611,212.111,216.611,218.699,221.201,225.701,227.789,232.289,236.285,238.373,242.873,247.373,250.874,253.376,255.878,258.38,262.88,266.876,268.964,271.961,276.461,279.458,281.546,285.542,290.042,292.544,295.046" svgx:width="0.5,0.5,0.25,0.5,0.83,0.25,0.5,0.33,0.25,0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">51.6% of 256 patients were found to be positive for anti-</text>
   <text y="702.955" x="62.36,65.861,71.864,73.961,78.461,80.963,83.96,88.46,91.961,94.058,98.054,102.554,105.056,107.558,112.058,116.558,121.058,123.56,127.556,131.057,133.145,137.141,139.643,141.74,146.24,150.74,154.241,158.237,160.739,162.836,167.336,170.333,172.43,176.93,179.432,182.933,186.929,190.925,194.426,198.422,200.672,202.769,209.267,213.767,215.864,219.86,224.36,227.357,230.354,234.35,236.852,240.848,243.35,245.852,250.352,254.852,256.94,261.44,264.437,266.534,270.53,275.03,277.532,280.034,284.534,289.034,293.534,298.034" svgx:width="0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.28,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.25,0.72,0.5,0.25,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">JC virus antibodies at onset of disease. No correlation of antibody </text>
   <text y="713.953" x="62.36,65.861,68.363,72.359,74.861,79.361,82.862,85.778,92.276,94.778,97.28,101.78,104.696,108.692,113.192,117.188,120.104,124.1,126.602,129.518,134.018,138.518,142.019,146.015,148.517,150.767,153.683,156.68,160.676,163.178,167.174,171.674,175.175,179.171,182.087,185.084,189.08,191.582,195.578,197.828,200.744,206.243,212.741,217.745,222.749,225.665,230.165,233.162,237.662,242.162,245.159,249.155,252.656,256.157,258.659,263.159,267.659,270.575,275.075,278.072,280.988,288.989,294.992,297.989" svgx:width="0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.5,0.44,0.25,0.44,0.28,0.25,0.5,0.5,0.39,0.44,0.28,0.25,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.25,0.61,0.72,0.56,0.56,0.25,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.89,0.67,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">status with age at onset, relapse rate, EDSS progression or MRI </text>
   <text y="724.951" x="62.36,64.862,68.858,72.359,74.861,79.361,83.861,85.796,88.298,92.798,96.794,101.294,103.229,109.727,113.723,117.224,119.159,122.156,126.656,131.156,135.656,140.156,142.406,143.846,150.344,154.844,158.84,161.342,165.842,169.838,172.34,176.84,181.34,183.275,187.775,192.275,196.775,198.71,201.707,206.207,208.709,211.211,215.711,222.209,225.206,229.706,234.206,236.141,239.642,243.638,246.635,251.135,258.137,260.072,263.573,267.569,274.571,279.071,281.573,285.569,289.07,291.005,293.507,298.007" svgx:width="0.28,0.44,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.5,0.25,0.72,0.44,0.39,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.25,0.72,0.5,0.44,0.28,0.5,0.44,0.28,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.33,0.5,0.28,0.28,0.5,0.72,0.33,0.5,0.5,0.25,0.39,0.44,0.33,0.5,0.78,0.25,0.39,0.44,0.78,0.5,0.28,0.44,0.39,0.25,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">lesion load was found. Analyzing 693 follow-up serum samples in </text>
  </g>
  <path style="fill:none;stroke:rgb(0,0,0);stroke-width:0.44;" d="M434.520 237.300 L473.250 237.300 "/>
  <g begin="text">
   <text y="77.103" x="310.016,314.516,319.016,323.516,325.334,329.834,333.83,336.332,338.834,342.83,347.33,349.832,353.333,355.151,361.649,365.645,367.463,370.46,374.96,379.46,383.96,388.46,390.278,394.778,397.28,401.78,406.28,408.098,410.6,413.102,415.604,419.6,422.597,424.415,427.916,430.418,434.414,438.914,441.416,443.918,446.42,448.922,453.422,455.24,459.236,463.736,468.236,470.054,474.05,478.55,480.368,484.364,488.864,493.364,497.864,501.86,504.362,506.18,510.176,514.676,519.176,523.676,527.672,530.669,534.17,536.672,541.172,545.672" svgx:width="0.5,0.5,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.72,0.44,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.25,0.28,0.28,0.28,0.44,0.33,0.25,0.39,0.28,0.44,0.5,0.28,0.28,0.28,0.28,0.5,0.25,0.44,0.5,0.5,0.25,0.44,0.5,0.25,0.44,0.5,0.5,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.5,0.44,0.33,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">154 patients we found high titer stability and an annual conversion </text>
   <text y="88.101" x="310.016,313.013,317.009,319.511,323.507,325.757,330.257,333.254,335.504,340.004,342.254,346.754,351.254,358.751" svgx:width="0.33,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.5,0.25,0.5,0.5,0.83,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">rate of 4.37%.</text>
   <text y="99.099" x="310.016,316.784,321.554,326.828,331.094,333.866,339.14,342.911,345.683,350.453,355.727,359.498,362.765" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="99.099" x="366.302,369.569,374.339,376.589,377.876,382.142,384.392,385.688,388.46,392.726,395.831,400.601,404.867,407.117,408.404,412.67,417.44,422.21,426.98,430.247,433.019,435.269,436.565,441.335,444.602,446.852,448.139,452.909,457.175,461.945,464.717,468.983,471.755,475.022,477.794,482.06,484.31,485.596,493.867,499.141,501.391,502.687,507.457,511.723,514.495,517.267,521.533,526.303,529.075,532.846,535.096,536.392,541.162,545.662" svgx:width="0.33,0.5,0.25,0.55,0.44,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.5,0.33,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.28,0.44,0.28,0.33,0.28,0.44,0.25,0.55,0.89,0.56,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">In a large cohort of pediatric MS patients no </text>
   <text y="110.097" x="310.016,314.282,319.052,321.824,326.594,330.86,335.63,339.896,344.162,346.772,353.54,357.806,361.577,364.187,367.454,372.224,376.994,381.764,386.534,389.144,391.916,396.686,400.952,403.724,406.333,410.104,414.37,417.637,422.407,427.177,431.947,435.718,438.49,441.262,444.034,448.804,451.576,454.348,459.118,461.728,464.995,469.765,473.032,475.642,479.908,484.678,487.45,490.222,493.489,497.26,503.533,506.143,510.913,513.685,516.952,521.722,525.493,528.103,532.369,537.139,539.911,542.683" svgx:width="0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.25,0.72,0.44,0.39,0.25,0.33,0.5,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.33,0.5,0.33,0.25,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.44,0.5,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">evidence was found that seropositivity for anti-JC virus anti-</text>
   <text y="121.095" x="310.016,314.786,319.556,324.326,327.098,331.364,335.135,336.962,339.734,343.505,345.332,349.598,353.369,357.14,361.91,366.176,368.948,373.214,375.986,380.252,385.022,386.849,393.617,396.389,399.161,403.931,405.758,410.024,411.851,415.622,419.888,424.658,428.924,432.191,436.457,438.284,442.549,445.322,448.094,452.863,455.635,459.901,464.167,466.939,468.766,473.032,477.802,482.572,485.839,489.61,493.876,496.396,498.223,503.497,508.267,511.534,516.304,519.571,522.343,526.114,528.886,533.656,538.426,541.198,545.698" svgx:width="0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.28,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.39,0.44,0.5,0.44,0.33,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.56,0.5,0.33,0.5,0.33,0.28,0.39,0.28,0.5,0.5,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">bodies is associated with a severe clinical course. Surprisingly </text>
   <text y="132.093" x="310.016,313.787,318.053,321.32,326.09,330.86,334.127,338.393,343.163,347.429,350.201,354.467,359.237,363.503,367.769,370.019,371.909,375.176,379.946,383.213,385.463,387.353,391.619,396.389,399.161,401.933,405.2,408.971,415.244,417.494,419.384,424.154,426.926,430.193,434.963,438.734,440.984,442.874,447.14,451.91,454.682,457.454,462.224,466.994,471.764,474.536,478.802,482.573,484.823,486.713,493.481,497.747,501.518,503.768,505.658,512.93,517.7,520.967,525.233,527.483,529.373,532.145,536.915,541.181,545.681" svgx:width="0.39,0.44,0.33,0.5,0.5,0.33,0.44,0.5,0.44,0.28,0.44,0.5,0.44,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.25,0.55,0.5,0.28,0.33,0.5,0.39,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.78,0.5,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">seroprevalence for anti-JC virus antibodies was more than </text>
   <text y="143.091" x="310.016,312.788,319.556,322.328,326.594,330.86,332.966,337.232,341.003,343.109,347.879,350.651,355.421,360.191,362.297,366.563,370.334,372.44,376.706,381.476,384.248,387.02,391.286,394.058,398.828,403.094,405.866,410.132,414.902,417.008,419.78,424.549,426.655,429.427,434.197,436.969,440.74,442.846,447.112,451.882,456.148,458.254,463.024,466.291,471.061,475.831,480.601,482.707,485.974,490.24,493.012,496.783,499.555,504.325,509.095,511.201,513.973,518.743,523.009,525.115,529.885,534.655,538.921,542.692" svgx:width="0.28,0.72,0.28,0.44,0.44,0.25,0.44,0.39,0.25,0.5,0.28,0.5,0.5,0.25,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25,0.44,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.25,0.33,0.44,0.28,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">twice as high as anticipated in this age group raising the ques-</text>
   <text y="154.089" x="310.016,312.788,315.56,320.33,325.1,327.134,329.906,333.173,335.207,337.979,342.749,347.015,349.049,351.821,356.591,359.858,364.124,368.39,371.162,373.934,378.704,383.474,385.508,392.276,395.048,397.82,402.59,404.624,408.395,414.668,416.702,421.472,424.244,427.511,432.281,436.052,438.086,440.858,445.628,449.894,453.161,457.427,461.693,465.464,469.73,473.501,475.535,478.307,483.077,487.342,489.376,492.643,495.415,499.186,503.956,505.99,508.762,513.532,515.566,520.336,524.602,529.372,533.638,536.41,541.18,545.68" svgx:width="0.28,0.28,0.5,0.5,0.25,0.28,0.33,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.39,0.67,0.25,0.5,0.28,0.33,0.5,0.39,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.39,0.25,0.28,0.5,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion if the infection with JC virus increases the risk to develop </text>
   <text y="165.087" x="310.016,318.287,323.561" svgx:width="0.89,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS.</text>
   <text y="192.087" x="310.016,315.515,320.015,324.515" svgx:width="0.61,0.5,0.5,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">P883</text>
   <text y="203.085" x="310.016,313.517,321.014,326.018,330.518,334.514,337.511,339.761,344.261,347.258,349.508,354.008,360.506,367.004,369.254,372.755,376.751,380.747,385.247,390.251,394.751,398.252,400.754,403.751,406.253,410.753,413.255,416.252,420.752,423.002,425.504,430.508,432.758,437.762,442.262,445.259,449.759,452.261,454.763,458.759,463.763,471.26,475.76,480.764,483.761,487.757,491.753,494.255,498.755,503.759,507.26,509.762,514.766,519.266" svgx:width="0.39,0.83,0.56,0.5,0.44,0.33,0.25,0.5,0.33,0.25,0.5,0.72,0.72,0.25,0.39,0.44,0.44,0.5,0.56,0.5,0.39,0.28,0.33,0.28,0.5,0.28,0.33,0.5,0.25,0.28,0.56,0.25,0.56,0.5,0.33,0.5,0.28,0.28,0.44,0.56,0.83,0.5,0.56,0.33,0.44,0.44,0.28,0.5,0.56,0.39,0.28,0.56,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Impact of JCV seropositivity in natalizumab-relapsing-</text>
   <text y="214.083" x="310.016,314.012,318.008,325.505,328.007,331.004,334.001,336.503,341.507,346.007,349.004,356.501,361.505,364.007,367.004,369.506,374.51,377.012,381.008,383.258,386.759,390.755,393.257,397.253,401.249,405.749,409.25,411.752,415.253,417.503,420.5,424.496,428.492,432.992,435.989,439.985,444.989,447.239,452.243,456.743,459.74,462.242,466.238,471.242,474.239,477.74,480.737,482.987,487.487,492.491" svgx:width="0.44,0.44,0.83,0.28,0.33,0.33,0.28,0.56,0.5,0.33,0.83,0.56,0.28,0.33,0.28,0.56,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.5,0.39,0.28,0.39,0.25,0.33,0.44,0.44,0.5,0.33,0.44,0.56,0.25,0.56,0.5,0.33,0.28,0.44,0.56,0.33,0.39,0.33,0.25,0.5,0.56,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">remitting-multiple sclerosis treated patients: an </text>
   <text y="225.081" x="310.016,314.516,319.52,323.021,327.017,331.013,335.513,340.013,343.01,345.512,350.012,355.016,359.516,362.018,364.268,367.769,370.766,375.77,380.774" svgx:width="0.5,0.56,0.39,0.44,0.44,0.5,0.5,0.33,0.28,0.5,0.56,0.5,0.28,0.25,0.39,0.33,0.56,0.56,0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">observational study</text>
   <text y="236.079" x="310.016,315.02,317.27,323.273,327.269,329.771,334.271,338.267,342.263" svgx:width="0.56,0.25,0.67,0.44,0.28,0.5,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">F Calocer</text>
   <text y="233.583" x="345.259" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="236.103" x="348.184,350.434,352.684,359.182,361.432,366.931,370.927,375.427,378.424,382.924" svgx:width="0.25,0.25,0.72,0.25,0.61,0.44,0.5,0.33,0.5,0.39" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, H Legros</text>
   <text y="233.583" x="386.425" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="236.103" x="389.35,391.6,393.85,399.853,402.103,408.106,412.606,417.106,420.103,423.1" svgx:width="0.25,0.25,0.67,0.25,0.67,0.5,0.5,0.33,0.33,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, B Bourre</text>
   <text y="233.583" x="427.095" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">2</text>
   <text y="236.103" x="430.02,432.27,434.52,441.018,443.268,449.766,453.762,456.759,460.755,464.751,469.251" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.33,0.44,0.44,0.5,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, N Derache</text>
   <text y="233.583" x="473.246" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="236.103" x="476.171,478.421,480.671,487.169,489.419,495.917,499.913,502.91,506.906" svgx:width="0.25,0.25,0.72,0.25,0.72,0.44,0.33,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">, G Defer</text>
   <text y="233.583" x="509.903" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:5.85px;stroke:none;">1</text>
   <text y="244.581" x="310.014" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">1</text>
   <text y="247.103" x="312.941,318.944,325.442,331.94,334.19,338.69,342.686,344.936,350.939,355.439,359.435,363.935,366.185,368.435,372.935,376.931,380.432,384.428,386.93,390.926,394.922,397.172,401.672,405.668,407.918,413.921,417.917,422.417,425.918,430.418,432.92,437.42,441.92,444.422,448.418,450.668,452.918,458.921,463.421,467.417,471.917,474.167,476.417,481.916,485.417,489.917,494.417,498.413,502.409,504.659" svgx:width="0.67,0.72,0.72,0.25,0.5,0.44,0.25,0.67,0.5,0.44,0.5,0.25,0.25,0.5,0.44,0.39,0.44,0.28,0.44,0.44,0.25,0.5,0.44,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.25,0.67,0.5,0.44,0.5,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44,0.25,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">CHU de Caen, Service de Neurologie, Caen, France, </text>
   <text y="244.583" x="506.906" svgx:width="0.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:5.85px;stroke:none;">2</text>
   <text y="247.103" x="509.831,515.834,522.332,528.83,531.08,535.58,539.576" svgx:width="0.67,0.72,0.72,0.25,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">CHU de </text>
   <text y="258.101" x="310.013,315.512,320.012,324.512,328.508,333.008,335.258,337.508,342.008,346.004,349.505,353.501,356.003,359.999,363.995,366.245,370.745,374.741,376.991,382.994,386.99,391.49,394.991,399.491,401.993,406.493,410.993,413.495,417.491,419.741,421.991,427.49,431.99,436.49,440.486,444.986,447.236,449.486,454.985,458.486,462.986,467.486,471.482" svgx:width="0.61,0.5,0.5,0.44,0.5,0.25,0.25,0.5,0.44,0.39,0.44,0.28,0.44,0.44,0.25,0.5,0.44,0.25,0.67,0.44,0.5,0.39,0.5,0.28,0.5,0.5,0.28,0.44,0.25,0.25,0.61,0.5,0.5,0.44,0.5,0.25,0.25,0.61,0.39,0.5,0.5,0.44,0.44" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.0px;stroke:none;">Rouen, Service de Neurologie, Rouen, France</text>
   <text y="285.101" x="310.013,316.016,320.516,324.512,329.516,334.016,337.85,342.35,347.354,352.358,357.362,360.359" svgx:width="0.67,0.5,0.44,0.56,0.5,0.44,0.5,0.56,0.56,0.56,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Background: </text>
   <text y="285.101" x="365.66,372.158,376.154,378.656,382.652,385.154,387.656,391.652,396.152,403.154,407.15,411.65,413.9,416.951,419.948,426.446,431.945,437.444,440.441,442.691,445.742,448.244,451.745,453.995,457.046,461.042,463.292,466.343,473.345,477.845,482.345,486.845,490.841,493.343,497.843,502.343,506.339,508.841,511.091,514.142,518.138,522.638,525.14,527.642,532.142,536.642,541.142,545.642" svgx:width="0.72,0.44,0.28,0.44,0.28,0.28,0.44,0.5,0.78,0.44,0.5,0.25,0.55,0.33,0.72,0.61,0.61,0.33,0.25,0.55,0.28,0.39,0.25,0.55,0.44,0.25,0.55,0.78,0.5,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">Natalizumab (NTZ) is a monoclonal antibody </text>
   <text y="296.099" x="310.013,314.513,317.015,320.012,324.008,328.004,330.506,334.502,339.002,341.567,345.563,350.063,354.059,356.561,361.061,364.562,367.064,369.629,374.345,377.342,381.842,384.407,386.909,391.409,393.911,397.907,402.407,405.404,407.906,412.406,416.402,419.903,422.459,426.455,430.955,435.455,438.452,442.952,447.452,451.448,455.948,458.513,461.51,466.01,469.008,471.573,476.073,478.575,483.075,487.575,490.077,494.577,497.142,501.138,505.134,507.636,510.138,514.638,518.634,521.19,524.187,528.183,530.685,534.681,539.181,542.682" svgx:width="0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.28,0.25,0.52,0.33,0.5,0.25,0.28,0.5,0.28,0.44,0.5,0.33,0.28,0.5,0.44,0.39,0.25,0.44,0.5,0.5,0.33,0.5,0.5,0.44,0.5,0.25,0.33,0.5,0.33,0.25,0.5,0.28,0.5,0.5,0.28,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.5,0.39,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">directed against α-4 integrines approved for highly active relaps-</text>
   <text y="307.097" x="310.013,312.515,317.015,321.515,324.512,327.509,331.505,338.507,341.009,343.511,346.013,348.515,353.015,357.515,359.693,366.695,371.195,373.697,376.199,378.701,383.201,385.703,389.699,391.878,395.379,399.375,401.877,405.873,408.87,413.37,416.871,420.867,424.368,426.546,429.543,437.544,442.548,445.545,447.795,449.973,456.471,460.467,463.968,468.468,470.97,473.472,477.468,479.646,484.146,488.142,495.144,499.644,504.144,507.645,510.147,513.144,517.14,519.642,523.638,528.138,530.316,534.312,537.147,540.144,542.646" svgx:width="0.28,0.5,0.5,0.33,0.33,0.44,0.78,0.28,0.28,0.28,0.28,0.5,0.5,0.25,0.78,0.5,0.28,0.28,0.28,0.5,0.28,0.44,0.25,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.44,0.39,0.25,0.33,0.89,0.56,0.33,0.25,0.25,0.72,0.44,0.39,0.5,0.28,0.28,0.44,0.25,0.5,0.44,0.78,0.5,0.5,0.39,0.28,0.33,0.44,0.28,0.44,0.5,0.25,0.44,0.33,0.33,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ing-remitting multiple scleroses (MS). Despite demonstrated effi-</text>
   <text y="318.095" x="310.013,314.009,316.511,320.507,325.007,329.003,333.503,335.996,340.496,344.996,347.489,351.989,354.491,357.992,361.988,365.984,369.485,373.481,375.974,379.97,384.47,388.97,391.967,395.468,399.464,401.714,404.207,410.705,416.204,421.703,424.196,426.698,430.199,432.692,437.192,441.692,444.689,449.189,452.186,454.688,459.188,463.688,467.684,470.186,474.182,476.685,481.185,483.678,487.674,491.175,494.676,499.176,503.172,505.674,509.67,512.172,516.168,520.668,523.161,529.659,532.161,534.663,539.163,541.656,545.651" svgx:width="0.44,0.28,0.44,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.44,0.5,0.5,0.33,0.39,0.44,0.25,0.25,0.72,0.61,0.61,0.25,0.28,0.39,0.25,0.5,0.5,0.33,0.5,0.33,0.28,0.5,0.5,0.44,0.28,0.44,0.28,0.5,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ciency on disease course, NTZ is unfortunately associated with a </text>
   <text y="329.093" x="310.013,313.01,315.512,319.013,323.513,325.763,327.455,331.955,334.952,337.202,338.894,343.394,347.39,351.89,355.886,358.388,362.888,367.388,369.89,374.39,378.89,381.14,382.832,387.332,390.329,394.829,399.329,402.326,406.322,409.823,413.324,415.826,420.326,424.322,426.572,428.255,435.257,439.757,442.259,444.761,447.263,450.26,454.76,458.756,462.752,465.254,467.504,469.196,471.698,475.694,480.194,484.694,489.194,493.19,497.69,501.686,505.682,510.182,514.682,518.678,521.18,525.68,530.18,534.176,536.678,541.178,545.678" svgx:width="0.33,0.28,0.39,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.44,0.25,0.55,0.78,0.5,0.28,0.28,0.28,0.33,0.5,0.44,0.44,0.28,0.25,0.55,0.28,0.44,0.5,0.5,0.5,0.44,0.5,0.44,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.44,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">risk of developing progressive multifocal leukoencephalopathy </text>
   <text y="340.091" x="310.013,313.01,318.014,326.015,331.514,334.511,336.509,339.011,343.511,347.507,350.009,352.007,354.509,358.505,363.005,365.003,367.505,372.005,374.003,377.0,380.996,384.497,386.999,389.996,392.498,396.494,398.996,401.498,405.998,410.498,412.496,416.996,420.497,424.493,426.491,430.991,434.987,439.487,443.483,447.983,452.483,454.985,459.485,463.985,465.983,470.483,473.48,475.478,480.482,488.483,493.649,495.647,498.644,501.146,504.647,509.147,511.145,514.646,517.148,520.145,524.141,526.643,529.145,532.142,534.644,538.64,542.636" svgx:width="0.33,0.56,0.89,0.61,0.33,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.33,0.44,0.39,0.28,0.33,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.39,0.44,0.25,0.5,0.44,0.5,0.44,0.5,0.5,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.39,0.28,0.33,0.44,0.28,0.28,0.33,0.28,0.44,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(PML) that led to restriction use depending of PML risk stratifica-</text>
   <text y="351.089" x="310.013,312.515,315.017,319.517,324.017,326.321,330.317,333.818,336.32,340.316,344.816,347.318,349.82,353.321,357.821,361.817,366.317,368.621,371.618,374.615,379.115,386.117,388.421,392.921,395.225,398.222,402.218,406.214,408.716,413.216,416.213,419.714,422.216,424.52,428.021,434.024,437.021,441.521,444.023,447.02,451.52,455.021,457.325,460.826,464.822,467.819,472.319,476.819,481.319,484.82,487.322,489.824,492.327,496.827,500.823,503.126,506.628,509.13,513.125,515.628,520.128,523.628,525.878,528.182,532.682,535.68,538.182,542.682,545.679" svgx:width="0.28,0.28,0.5,0.5,0.25,0.44,0.39,0.28,0.44,0.5,0.28,0.28,0.39,0.5,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.28,0.25,0.39,0.67,0.33,0.5,0.28,0.33,0.5,0.39,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.25,0.5,0.33,0.28,0.5,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">tion established from 3 factors: JC-virus seropositive status, prior </text>
   <text y="362.087" x="310.013,312.515,319.517,326.519,331.019,335.519,339.515,341.765,344.825,347.327,351.827,355.823,358.82,362.816,367.316,371.816,374.066,377.126,381.122,385.622,390.122,392.372,395.432,397.934,400.931,404.927,408.923,411.425,418.427,422.423,426.923,429.425,431.675,434.735,438.731,443.231,447.731,452.231,455.732,460.232,463.229,467.225,469.475,472.535,477.035,481.535,484.532,488.528,491.03,493.533,498.033,502.533,504.783,507.842,510.84,515.339,519.839,523.835,526.832,529.082,532.142,534.644,541.142,545.642" svgx:width="0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.44,0.33,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.55,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.44,0.33,0.25,0.55,0.28,0.72,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">immune therapy and treatment exposure duration (over two </text>
   <text y="373.085" x="310.013,314.513,318.509,322.505,325.502,329.003,332.0,334.25,336.086,339.083,343.583,345.419,349.415,351.251,355.247,358.244,362.24,366.236,368.738,371.735,374.237,376.739,379.736,383.732,387.728,389.564,393.56,396.062,398.564,403.064,405.566,409.562,413.558,416.06,417.896,421.397,425.393,427.896,430.398,432.9,437.4,441.9,444.15,445.986,448.488,452.988,456.984,458.82,461.322,468.324,472.824,476.82,480.816,483.318,485.154,489.654,492.651,494.487,496.989,501.489,503.991,507.492,509.328,512.325,514.827,518.328,522.828,524.664,528.165,530.667,533.664,537.66,540.162,542.664" svgx:width="0.5,0.44,0.44,0.33,0.39,0.33,0.25,0.25,0.33,0.5,0.25,0.44,0.25,0.44,0.33,0.44,0.44,0.28,0.33,0.28,0.28,0.33,0.44,0.44,0.25,0.44,0.28,0.28,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.44,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.33,0.28,0.39,0.5,0.25,0.39,0.28,0.33,0.44,0.28,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">years). In a “real-life” clinical setting, the impact of this risk strati-</text>
   <text y="384.083" x="310.013,313.01,315.512,319.508,323.504,326.006,328.508,333.008,337.508,339.758,341.054,345.554,350.054,352.304,353.6,358.1,362.6,367.1,370.601,373.103,377.099,379.601,383.597,388.097,390.347,391.643,396.143,400.139,404.135,406.637,410.138,412.64,417.14,421.64,423.89,425.186,429.182,433.682,438.182,440.432,441.728,446.228,450.224,453.221,455.723,458.225,462.221,466.721,469.223,473.219,476.216,478.718,483.218,485.468,486.764,490.265,496.268,502.604,504.854,506.15,509.651,513.647,516.644,521.144,523.646,528.146,532.646,535.148,539.144,543.14,545.642" svgx:width="0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.44,0.28,0.39,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.44,0.33,0.28,0.28,0.44,0.5,0.28,0.44,0.33,0.28,0.5,0.25,0.55,0.39,0.67,0.72,0.25,0.55,0.39,0.44,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">fication on physician decision and particularly JCV serological </text>
   <text y="395.081" x="310.013,313.514,316.016,320.012,322.514,327.014,330.515,332.765,337.265,341.261,344.762,347.012,351.512,355.508,359.504,364.004,366.254,369.251,373.247,376.244,380.24,382.742,387.242,389.492,393.488,397.988,401.984,404.486,408.986,412.982,415.484,419.48,423.98" svgx:width="0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.5,0.44,0.39,0.25,0.5,0.44,0.44,0.5,0.25,0.33,0.44,0.33,0.44,0.28,0.5,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">status has been rarely evaluated.</text>
   <text y="406.079" x="310.013,317.015,322.019,325.016,329.012,333.008,336.005,338.507,343.007,347.003,350.504,353.501" svgx:width="0.78,0.56,0.33,0.44,0.44,0.33,0.28,0.5,0.44,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Objectives: </text>
   <text y="406.079" x="356.282,361.781,366.281,370.277,373.058,377.558,382.058,384.56,388.556,392.552,395.054,397.556,402.056,406.052,408.833,415.331,419.327,422.828,425.609,428.111,432.611,435.392,438.893,441.395,445.895,450.395,454.895,457.676,460.178,464.678,468.674,471.455,473.957,480.959,485.459,489.455,493.451,495.953,498.734,503.234,506.231,509.012,512.513,518.516,524.852,527.633,531.134,535.13,538.127,542.627" svgx:width="0.61,0.5,0.44,0.25,0.5,0.5,0.28,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.72,0.44,0.39,0.25,0.28,0.5,0.25,0.39,0.28,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.39,0.67,0.72,0.25,0.39,0.44,0.33,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">The objective was to study the impact of JCV sero-</text>
   <text y="417.077" x="310.013,314.513,319.013,322.514,325.016,327.518,330.02,334.52,337.022,339.524,344.024,346.274,347.093,349.595,354.095,356.345,357.164,363.662,369.161,374.66,377.657,383.66,389.663,392.66,400.661,405.665,407.915,408.734,411.236,414.233,418.229,422.225,424.727,428.723,433.223,435.473,436.292,440.792,444.788,447.29,449.792,453.788,458.288,460.79,464.291,466.541,468.791,469.61,476.108,481.607,487.106,489.356,490.175,494.675,497.177,500.678,504.674,509.174,513.674,516.176,518.678,523.178,527.678,531.674,534.176,536.678,541.178,545.678" svgx:width="0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.72,0.61,0.61,0.33,0.67,0.67,0.33,0.89,0.56,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">positivity in NTZ-RR-MS treated patients. NTZ discontinuation </text>
   <text y="428.075" x="310.013,314.513,318.509,322.505,325.007,328.508,331.01,335.51,340.01,343.007,350.009,354.005,358.505,361.007,365.507,370.007,372.068,378.566,382.562,386.063,388.124,392.12,396.62,403.622,408.122,412.118,415.115,419.111,423.611,425.672,428.174,432.674,434.735,437.237,441.737,446.237,448.739,453.239,455.741,460.241,464.741,468.737,471.24,473.301,476.298,478.8,482.301,486.801,488.862,493.362,496.359,498.42,503.424,511.425,516.591,518.652,523.152,527.148,530.145,532.647,537.147,541.143,545.643" svgx:width="0.5,0.44,0.44,0.28,0.39,0.28,0.5,0.5,0.33,0.78,0.44,0.5,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.44,0.5,0.78,0.5,0.44,0.33,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.5,0.5,0.44,0.28,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.33,0.25,0.56,0.89,0.61,0.25,0.5,0.44,0.33,0.28,0.5,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">decision-making was compared to individual risk of PML defined </text>
   <text y="439.073" x="310.013,314.513,319.013,321.263,323.765,326.267,329.768,332.018,335.519,338.021,341.018,345.014,347.516,350.018,353.015,355.517,359.513,363.509,366.011,368.513,373.013,377.513" svgx:width="0.5,0.5,0.25,0.28,0.28,0.39,0.25,0.39,0.28,0.33,0.44,0.28,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">by its stratification.</text>
   <text y="450.071" x="310.013,318.509,322.505,325.502,330.506,335.006,340.01,343.511,346.508" svgx:width="0.94,0.44,0.33,0.56,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Methods: </text>
   <text y="450.071" x="349.019,357.02,362.024,364.535,369.035,373.031,375.533,378.035,382.031,386.531,389.033,392.534,395.045,398.042,401.039,405.539,412.541,415.052,417.554,424.052,428.552,431.063,436.067,439.064,443.06,447.56,451.556,456.056,458.567,466.568,471.572,474.083,478.079,482.075,486.575,489.077,493.073,496.07,499.571,501.821,504.332,510.83,515.33,519.83,523.331,527.327,529.838,533.339,539.342,545.678" svgx:width="0.89,0.56,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.72,0.5,0.25,0.56,0.33,0.44,0.5,0.44,0.5,0.25,0.89,0.56,0.25,0.44,0.44,0.5,0.28,0.44,0.33,0.39,0.25,0.25,0.72,0.5,0.5,0.39,0.44,0.25,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">MS patients from two French MS centers, whose JCV </text>
   <text y="461.069" x="310.013,313.514,317.51,320.507,325.007,327.509,332.009,336.509,339.011,343.007,347.003,349.505,351.521,355.022,357.524,361.52,364.022,368.522,372.023,374.039,380.537,384.533,388.034,390.05,394.55,399.05,403.55,410.048,414.548,416.573,420.569,425.069,429.569,431.585,438.083,443.582,449.081,451.097,453.599,456.596,460.592,464.588,467.09,474.092,478.088,482.588,485.09,487.106,491.606,496.106,499.103,503.099,505.601,508.103,512.603,517.103,519.128,525.626,529.622,533.123,535.139,538.64,541.142,545.642" svgx:width="0.39,0.44,0.33,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.39,0.28,0.44,0.28,0.5,0.39,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.5,0.72,0.5,0.25,0.44,0.5,0.5,0.25,0.72,0.61,0.61,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">serological status was known and NTZ treatment duration was six </text>
   <text y="472.067" x="310.013,317.015,321.515,326.015,328.517,333.017,336.518,338.768,341.666,348.668,351.17,355.67,358.172,365.174,369.674,376.676,378.926,381.824,388.322,392.318,395.315,399.311,401.561,404.459,406.961,411.461,415.457,417.959,422.459,426.959,430.955,435.455,437.705,440.603,445.103,449.099,451.602,458.099,462.095,466.091,470.591,472.841,475.74,482.237,486.233,488.736,493.236,497.736,501.732,504.729,506.979,509.877,514.377,518.877,523.044,527.544,529.794,532.692,536.688,541.188,545.688" svgx:width="0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.55,0.78,0.28,0.5,0.28,0.78,0.5,0.78,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.55,0.72,0.44,0.28,0.5,0.5,0.44,0.33,0.25,0.55,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">months minimum were included between October 2011 and </text>
   <text y="483.065" x="310.013,316.511,320.507,324.503,328.499,335.501,340.001,343.997,346.994,349.352,353.852,358.352,362.852,367.352,369.602,371.465,377.963,381.959,385.955,390.455,393.452,397.952,400.454,404.954,409.454,411.812,416.816,424.817,429.983,432.341,435.338,437.84,441.341,445.841,448.199,451.7,454.202,457.199,461.195,463.697,466.199,469.196,471.698,475.694,479.69,482.192,484.694,489.194,493.694,495.944,498.302,504.8,508.796,511.154,515.15,519.65,523.646,526.148,530.648,534.644,537.146,541.142,545.642" svgx:width="0.72,0.44,0.44,0.44,0.78,0.5,0.44,0.33,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.72,0.44,0.44,0.5,0.33,0.5,0.28,0.5,0.5,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.39,0.28,0.33,0.44,0.28,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.72,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">December 2013. According PML risk stratification, we evaluated </text>
   <text y="494.063" x="310.013,314.009,316.259,321.263,329.264,334.43,336.68,339.677,342.179,345.68,350.18,352.43,354.932,358.928,363.428,367.424,369.926,372.176,375.173,379.673,382.67,384.92,388.916,391.418,393.92,396.17,400.67,404.666,407.168,409.67,413.666,418.166,420.668,424.169" svgx:width="0.44,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.28,0.44,0.5,0.44,0.28,0.25,0.33,0.5,0.33,0.25,0.44,0.28,0.28,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">a PML risk level for all patients.</text>
   <text y="505.061" x="310.013,316.511,320.507,324.008,329.012,331.514,334.511,338.012,341.009" svgx:width="0.72,0.44,0.39,0.56,0.28,0.33,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Results: </text>
   <text y="505.061" x="346.472,350.972,355.472,359.972,362.222,365.435,373.436,378.44,381.437,385.937,389.933,392.435,394.937,398.933,403.433,405.935,409.436,411.686,414.899,417.896,422.396,426.896,429.146,432.359,435.356,439.352,446.354,450.35,452.852,456.848,460.349,462.599,465.812,469.808,474.308,478.808,481.058,484.271,488.771,493.271,495.521,498.734,505.737,509.733,512.234,516.23,519.731,522.728,524.978,528.191,534.689,538.685,541.682,545.678" svgx:width="0.5,0.5,0.5,0.25,0.55,0.89,0.56,0.33,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.55,0.33,0.5,0.5,0.25,0.55,0.33,0.44,0.78,0.44,0.28,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.39,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">121 MS-patients (86 females and 35 males) were </text>
   <text y="516.059" x="310.013,312.515,317.015,321.011,323.513,328.013,332.513,336.509,341.009,343.259,345.932,353.933,357.929,361.925,366.425,369.098,373.094,377.594,381.59,384.263,390.761,394.757,398.258,400.931,405.431,409.931,412.604,417.104,421.1,425.096,428.093,431.594,433.844,436.517,443.519,447.515,451.511,456.011,458.684,463.184,465.686,469.187,473.183,477.179,480.68,484.676,487.349,491.849,496.349,499.346,503.342,505.844,508.346,512.846,517.346,520.019,526.517,530.513,534.014,536.687,541.187,545.687" svgx:width="0.28,0.5,0.44,0.28,0.5,0.5,0.44,0.5,0.25,0.25,0.89,0.44,0.44,0.5,0.25,0.44,0.5,0.44,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.33,0.39,0.25,0.25,0.78,0.44,0.44,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.72,0.44,0.39,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">included. Mean age was 41 years, mean disease duration was 13 </text>
   <text y="527.057" x="310.013,314.513,318.509,322.505,325.502,329.003,331.496,335.492,339.992,344.492,346.985,353.987,357.983,362.483,364.985,368.981,373.481,375.974,381.473,387.971,392.975,397.979,400.472,406.97,410.966,414.467,416.96,421.46,423.71,426.203,434.204,438.2,442.196,446.696,449.189,453.689,458.189,461.186,465.182,467.684,470.186,474.686,479.186,481.679,486.179,489.176,491.669,498.167,503.666,509.165,511.658,514.16,517.157,521.153,525.149,527.651,534.653,538.649,543.149,545.651" svgx:width="0.5,0.44,0.44,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.5,0.25,0.61,0.72,0.56,0.56,0.25,0.72,0.44,0.39,0.25,0.5,0.25,0.25,0.89,0.44,0.44,0.5,0.25,0.5,0.5,0.33,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.61,0.61,0.25,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">years and median EDSS was 3. Mean duration of NTZ treatment </text>
   <text y="538.055" x="310.013,316.511,320.507,324.008,326.492,330.992,335.492,337.976,344.978,349.478,353.978,356.48,360.98,364.481,366.731,368.72,375.218,382.22,386.72,391.22,395.72,398.204,400.706,405.206,409.202,411.686,416.186,420.182,422.684,425.186,429.182,433.682,436.184,439.685,441.935,444.419,446.921,451.421,455.417,457.901,460.898,464.895,467.397,471.393,473.877,478.377,481.374,483.858,487.359,493.362,499.698,502.182,505.683,509.679,512.676,517.176,521.676,526.176,529.677,532.179,534.681,537.183,541.683,545.679" svgx:width="0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.72,0.78,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.39,0.67,0.72,0.25,0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was 38 months. Among the patients, the rate of JCV seropositive </text>
   <text y="549.053" x="310.013,316.511,320.507,324.008,325.763,330.263,334.763,337.013,341.513,349.01,350.765,353.762,358.262,362.762,365.264,369.764,374.264,378.764,381.761,384.011,385.766,390.266,394.766,402.263,404.018,407.015,411.515,416.015,418.517,423.017,427.517,432.017,435.014,436.769,441.269,445.265,449.765,451.52,455.516,457.271,461.771,464.273,468.773,473.273,477.269,480.266,482.021,487.025,495.026,500.192,501.947,504.944,507.446,510.947,515.448,517.203,521.703,525.698,529.694,533.69,538.19,541.691,545.687" svgx:width="0.72,0.44,0.39,0.25,0.5,0.5,0.25,0.5,0.83,0.25,0.33,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.25,0.25,0.5,0.5,0.83,0.25,0.33,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.25,0.5,0.44,0.5,0.25,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.44,0.44,0.44,0.5,0.39,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">was 71,9% (87/121). 12% (15/121) had a higher PML risk because </text>
   <text y="560.051" x="310.013,314.513,317.51,319.607,322.109,326.609,330.605,332.702,337.202,340.199,344.195,347.696,351.692,356.192,360.188,364.184,366.281,370.781,373.778,375.875,378.377,382.877,385.874,389.87,393.866,395.963,398.96,401.462,404.963,409.463,411.56,414.557,418.553,422.549,425.051,429.551,432.548,436.049,438.146,442.142,446.642,451.142,453.239,457.739,462.239,464.336,471.833,473.93,476.927,479.024,483.524,488.024,490.526,495.026,499.526,504.026,507.023,509.12,513.116,515.213,517.715,522.215,524.717,528.713,531.71,538.712,542.708" svgx:width="0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.44,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.33,0.44,0.44,0.25,0.33,0.28,0.39,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.25,0.83,0.25,0.33,0.25,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.25,0.44,0.25,0.28,0.5,0.28,0.44,0.33,0.78,0.44,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">of the presence of three risk factors and 43 % ( 52/121) a interme-</text>
   <text y="571.049" x="310.013,314.513,317.015,321.011,324.008,328.508,330.875,333.872,336.374,339.875,344.375,346.742,351.242,355.238,359.234,363.23,367.73,371.231,375.227,377.594,380.096,384.596,388.592,393.092,395.459,399.959,403.955,408.455,410.822,413.324,419.822,424.322,426.689,429.686,433.682,437.678,440.18,444.68,447.677,451.178,453.545,458.549,466.55,471.716,474.083,477.08,479.582,483.083,487.583,491.085,493.452,495.954,500.454,504.45,506.952,511.452,515.952,518.454,522.954,527.454,529.821,533.322,539.325,545.661" svgx:width="0.5,0.28,0.44,0.33,0.5,0.25,0.33,0.28,0.39,0.5,0.25,0.5,0.44,0.44,0.44,0.5,0.39,0.44,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.44,0.5,0.25,0.28,0.72,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.39,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">diary risk because they had two factors PML risks including JCV </text>
   <text y="582.047" x="310.013,313.514,317.51,320.507,325.007,329.507,334.007,337.508,340.01,342.512,345.014,349.514,353.51,355.985,359.981,364.481,368.981,371.456,377.954,383.453,388.952,391.427,395.423,399.923,404.423,408.923,412.424,416.924,419.921,423.917,426.392,433.394,437.894,440.891,444.887,447.362,449.864,454.364,458.36,462.86,465.335,469.835,474.335,476.81,483.812,488.312,492.812,495.314,499.814,503.315,505.565,508.04,513.044,521.045,526.211,528.686,531.683,534.185,537.686,542.186,545.687" svgx:width="0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.25,0.72,0.61,0.61,0.25,0.44,0.5,0.5,0.5,0.39,0.5,0.33,0.44,0.25,0.78,0.5,0.33,0.44,0.25,0.28,0.5,0.44,0.5,0.25,0.5,0.5,0.25,0.78,0.5,0.5,0.28,0.5,0.39,0.25,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.39,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">seropositive and NTZ exposure more than 24 months. PML risks </text>
   <text y="593.045" x="310.013,313.01,317.51,320.507,322.955,327.455,329.957,334.457,338.453,341.45,344.951,347.399,351.899,355.895,358.397,360.899,364.895,369.395,371.897,375.398,377.837,380.834,385.334,389.834,397.331,399.833,402.281,406.781,411.281,413.783,418.283,422.783,427.283,430.28,432.728,439.226,443.222,446.723,449.162,453.158,456.659,460.16,464.156,467.657,471.158,475.154,479.654,482.102,484.604,489.104,495.602,499.598,502.1,504.35,506.798,509.796,514.296,516.744,519.246,523.746,527.742,530.19,533.69,538.19,542.69" svgx:width="0.33,0.5,0.33,0.25,0.5,0.28,0.5,0.44,0.33,0.39,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.33,0.5,0.5,0.83,0.28,0.25,0.5,0.5,0.28,0.5,0.5,0.5,0.33,0.25,0.72,0.44,0.39,0.25,0.44,0.39,0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.72,0.44,0.33,0.25,0.25,0.33,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">for others patients (55%: 54/121) was assessed lower. In the sub-</text>
   <text y="604.043" x="310.013,314.513,317.51,322.01,326.51,331.01,333.233,337.733,340.73,342.953,347.453,351.449,353.951,356.453,360.449,364.949,367.451,369.674,376.172,378.674,381.176,385.676,387.899,391.895,394.118,398.618,401.12,405.62,410.12,414.116,417.113,419.336,424.34,432.341,437.507,439.73,442.727,445.229,448.73,453.23,455.48,457.703,462.203,466.703,474.2,476.423,479.42,483.92,488.42,490.922,495.422,499.922,502.919,505.142,509.642,512.144,515.645,519.641,524.141,528.641,531.143,533.645,538.145,542.645" svgx:width="0.5,0.33,0.5,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.72,0.28,0.28,0.5,0.25,0.44,0.25,0.5,0.28,0.5,0.5,0.44,0.33,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.25,0.5,0.5,0.83,0.25,0.33,0.5,0.5,0.28,0.5,0.5,0.33,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">group of patient with a higher PML risk, 93% (14/15) discontinu-</text>
   <text y="615.041" x="310.013,314.009,316.511,320.507,325.007,326.897,333.395,338.894,344.393,346.283,350.279,354.779,358.775,363.275,365.165,367.667,372.167,376.667,381.167,385.667,390.167,392.669,394.559,398.555,401.057,403.559,405.449,409.949,412.946,414.836,418.337,424.34,430.676,432.566,436.067,440.063,443.06,447.56,452.06,456.056,460.556,464.552,467.055,469.557,474.057,478.053,479.943,484.443,488.439,490.941,493.443,497.439,501.939,504.441,507.942,509.823,513.819,517.815,520.812,523.809,526.311,530.307,534.807,536.697,541.197,545.697" svgx:width="0.44,0.28,0.44,0.5,0.25,0.72,0.61,0.61,0.25,0.44,0.5,0.44,0.5,0.25,0.28,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.44,0.28,0.28,0.25,0.5,0.33,0.25,0.39,0.67,0.72,0.25,0.39,0.44,0.33,0.5,0.5,0.44,0.5,0.44,0.28,0.28,0.5,0.44,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.44,0.33,0.33,0.28,0.44,0.5,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">ated NTZ even thought all of JCV seronegative patients carried on </text>
   <text y="626.039" x="310.013,312.515,315.512,319.508,323.504,326.006,333.008,337.004,341.504,344.006,346.256,348.776,351.773,356.273,358.793,361.295,365.795,368.297,372.293,375.29,382.292,386.288,390.788,393.29,397.286,400.283,404.783,407.303,410.804,415.304,419.804,422.801,427.301,430.298,434.798,439.298,443.798,446.048,448.568,455.066,460.565,466.064,468.584,475.082,479.078,482.579,485.099,488.6,491.102,495.602,500.102,504.602,508.598,513.098,515.618,518.12,522.62,525.14,529.64,534.14,536.642,541.142,545.642" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.33,0.5,0.25,0.28,0.5,0.28,0.44,0.33,0.78,0.44,0.5,0.28,0.44,0.33,0.5,0.25,0.39,0.5,0.5,0.33,0.5,0.33,0.5,0.5,0.5,0.25,0.25,0.72,0.61,0.61,0.25,0.72,0.44,0.39,0.25,0.39,0.28,0.5,0.5,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment. In intermediary sub-group, NTZ was stopped in 24/52 </text>
   <text y="637.037" x="310.013,313.01,317.51,322.01,329.507,332.504,334.754,336.401,340.901,344.897,347.399,349.901,353.897,358.397,360.899,364.4,366.65,368.9,370.385,375.884,380.384,384.38,386.63,388.277,395.279,399.275,401.777,406.277,408.527,410.174,413.171,417.167,421.163,424.664,429.164,433.664,435.914,437.561,442.061,445.058,447.308,448.955,451.457,455.957,458.46,462.456,465.453,468.45,472.95,477.45,479.952,482.454,486.954,491.454,493.704,495.351,501.849,507.348,512.847,515.097,516.744,523.242,527.237,530.738,532.988,534.635,537.137,541.637,545.633" svgx:width="0.33,0.5,0.5,0.83,0.33,0.25,0.55,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.78,0.44,0.28,0.5,0.25,0.55,0.33,0.44,0.44,0.39,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.33,0.5,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.61,0.61,0.25,0.55,0.72,0.44,0.39,0.25,0.55,0.28,0.5,0.44,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">(46%) patients. The main reason of interrupting NTZ was the </text>
   <text y="648.035" x="310.013,315.017,323.018,328.184,330.434,333.431,335.933,339.434,343.934,346.184,348.686,353.186,355.436,359.936,364.436,371.933,374.183,378.683,381.68,383.93,386.432,390.932,393.434,396.935,399.185,403.181,407.681,412.181,416.681,419.678,422.18" svgx:width="0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.28,0.5,0.25,0.5,0.5,0.83,0.25,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.44,0.5,0.5,0.5,0.33,0.28,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">PML risk in 55% of this cohort.</text>
   <text y="659.033" x="310.013,316.511,321.011,326.015,330.011,332.513,337.517,341.018,343.52,348.02,353.024,356.525,359.522" svgx:width="0.72,0.5,0.56,0.44,0.28,0.56,0.39,0.28,0.5,0.56,0.39,0.33,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:9.0px;stroke:none;">Conclusions: </text>
   <text y="659.033" x="365.885,371.384,375.884,378.386,381.887,384.137,388.25,392.75,397.25,400.751,404.747,407.744,412.244,416.24,418.742,421.244,425.744,430.244,434.24,436.742,438.992,443.105,446.606,449.108,453.608,458.108,462.608,464.858,468.971,471.968,476.468,480.968,485.468,489.968,492.218,496.331,500.327,502.577,506.69,510.686,515.186,518.183,521.18,525.176,527.678,531.674,534.176,536.678,541.178,545.678" svgx:width="0.61,0.5,0.28,0.39,0.25,0.55,0.5,0.5,0.39,0.44,0.33,0.5,0.44,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.25,0.55,0.44,0.5,0.33,0.33,0.44,0.28,0.44,0.28,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">This observational study found a correlation </text>
   <text y="670.031" x="310.013,314.513,318.509,321.011,327.509,331.505,335.501,340.001,342.692,345.194,349.694,353.69,356.381,361.385,369.386,374.552,377.243,380.24,382.742,386.243,390.743,393.434,397.43,401.93,406.43,409.121,411.623,416.123,420.119,422.81,425.807,429.803,432.305,436.301,438.992,443.492,446.489,449.18,455.678,461.177,466.676,469.367,473.867,476.369,479.87,483.866,488.366,492.866,495.368,497.871,502.371,506.871,510.867,513.369,515.871,520.371,524.871,527.121,529.812,533.313,539.315,545.651" svgx:width="0.5,0.44,0.28,0.72,0.44,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.33,0.44,0.28,0.44,0.25,0.5,0.33,0.25,0.72,0.61,0.61,0.25,0.5,0.28,0.39,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.39,0.67,0.72,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">between the PML risk and the rate of NTZ discontinuation. JCV </text>
   <text y="681.029" x="310.013,313.514,317.51,320.507,325.007,329.507,334.007,337.508,340.01,342.512,345.014,349.514,352.016,354.518,359.018,361.259,365.759,369.755,374.255,376.496,380.492,382.733,385.73,389.726,393.722,396.224,398.465,400.967,407.969,412.469,416.465,420.461,422.963,425.204,429.704,434.204,436.445,440.945,444.941,448.937,451.439,454.94,457.443,461.943,466.443,468.684,471.186,475.686,477.927,481.923,485.919,488.916,491.913,496.413,498.654,503.154,507.654,509.895,516.393,518.895,521.397,525.897,528.138,534.636,540.135,545.634" svgx:width="0.39,0.44,0.33,0.5,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.44,0.5,0.25,0.44,0.25,0.33,0.44,0.44,0.28,0.25,0.28,0.78,0.5,0.44,0.44,0.28,0.25,0.5,0.5,0.25,0.5,0.44,0.44,0.28,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.44,0.33,0.33,0.5,0.25,0.5,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.72,0.61,0.61,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">seropositivity had a real impact on decision to carry on with NTZ </text>
   <text y="692.027" x="310.013,312.515,315.512,319.508,323.504,326.006,333.008,337.004,341.504,344.006,346.256,348.884,353.888,361.889,367.055,369.683,372.68,375.182,378.683,383.183,385.811,389.312,391.814,394.811,398.807,401.309,403.811,406.808,409.31,413.306,417.302,419.804,422.306,426.806,431.306,433.934,436.436,439.938,442.565,446.561,449.189,451.691,456.191,460.691,463.194,465.822,470.322,473.823,476.325,480.825,485.325,487.953,490.455,494.955,497.583,501.579,504.576,508.572,512.568,515.07,518.067,520.569,523.071,526.068,530.064,534.06,536.688,541.188,545.688" svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.25,0.56,0.89,0.61,0.25,0.33,0.28,0.39,0.5,0.25,0.39,0.28,0.33,0.44,0.28,0.28,0.33,0.28,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.39,0.25,0.44,0.25,0.28,0.5,0.5,0.28,0.25,0.5,0.39,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.33,0.44,0.44,0.28,0.33,0.28,0.28,0.33,0.44,0.44,0.25,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">treatment. PML risk stratification is a tool using in “real-life” by </text>
   <text y="703.025" x="310.013,314.513,319.013,323.513,327.014,329.516,333.512,336.014,340.01,344.51,346.634,349.136,353.636,355.76,360.26,362.762,366.263,370.259,374.759,378.26,381.761,383.885,390.383,395.882,401.381,403.505,407.501,412.001,416.501,419.003,421.505,426.005,430.505,434.501,437.003,439.505,444.005,448.505,450.629,453.131,457.631,459.755,463.751,467.747,471.743,476.243,478.367,482.867,486.863,489.365,491.867,495.863,500.363,502.865,505.115,507.077,512.576,517.076,521.072,523.196,527.696,531.692,536.192,540.188,542.69" svgx:width="0.5,0.5,0.5,0.39,0.28,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.5,0.28,0.39,0.44,0.5,0.39,0.39,0.25,0.72,0.61,0.61,0.25,0.44,0.5,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.44,0.44,0.44,0.5,0.25,0.5,0.44,0.28,0.28,0.44,0.5,0.28,0.25,0.25,0.61,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.28,0.33" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">physician to discuss NTZ continuation in each patient. The devel-</text>
   <text y="714.023" x="310.013,314.513,319.013,326.015,330.011,334.511,337.013,339.263,340.55,345.05,348.047,350.297,351.584,355.58,360.08,362.582,365.084,368.081,371.582,377.585,383.921,386.171,387.458,391.454,395.954,398.456,400.958,405.458,409.958,414.458,418.958,421.208,422.495,424.997,429.497,433.997,437.993,442.493,444.743,446.03,453.032,457.028,461.528,463.778,465.065,469.061,471.563,474.065,478.565,485.063,489.059,493.559,495.809,497.096,501.596,506.096,510.596,514.097,516.599,520.595,523.097,527.093,531.593,535.094,537.344,538.631,541.133,545.633" svgx:width="0.5,0.5,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.39,0.67,0.72,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.39,0.28,0.44,0.28,0.44,0.5,0.39,0.25,0.55,0.28,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">opment of anti-JCV antibody index may allowed physicians to </text>
   <text y="725.021" x="310.013,313.01,317.006,320.003,322.505,327.005,331.001,333.251,337.751,340.253,343.754,346.004,350.504,354.5,358.496,360.998,364.499,367.001,371.501,376.001" svgx:width="0.33,0.44,0.33,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.25,0.5,0.44,0.44,0.28,0.39,0.28,0.5,0.5,0.25" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.0px;stroke:none;">refine his decision.</text>
  </g>
 </g>
</svg>
